Financial Survey: iKang Healthcare Group (KANG) vs. The Competition

iKang Healthcare Group (NASDAQ: KANG) is one of 43 publicly-traded companies in the “Healthcare Facilities & Services” industry, but how does it compare to its peers? We will compare iKang Healthcare Group to similar businesses based on the strength of its analyst recommendations, dividends, earnings, valuation, risk, institutional ownership and profitability.

Institutional & Insider Ownership

32.4% of iKang Healthcare Group shares are held by institutional investors. Comparatively, 73.9% of shares of all “Healthcare Facilities & Services” companies are held by institutional investors. 13.6% of shares of all “Healthcare Facilities & Services” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and price targets for iKang Healthcare Group and its peers, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iKang Healthcare Group 0 0 0 0 N/A
iKang Healthcare Group Competitors 242 1431 1879 38 2.48

As a group, “Healthcare Facilities & Services” companies have a potential upside of 7.85%. Given iKang Healthcare Group’s peers higher probable upside, analysts clearly believe iKang Healthcare Group has less favorable growth aspects than its peers.

Volatility & Risk

iKang Healthcare Group has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500. Comparatively, iKang Healthcare Group’s peers have a beta of 0.71, suggesting that their average stock price is 29% less volatile than the S&P 500.

Valuation and Earnings

This table compares iKang Healthcare Group and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
iKang Healthcare Group $435.71 million -$11.25 million 401.25
iKang Healthcare Group Competitors $6.63 billion $198.10 million 259.79

iKang Healthcare Group’s peers have higher revenue and earnings than iKang Healthcare Group. iKang Healthcare Group is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.


This table compares iKang Healthcare Group and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
iKang Healthcare Group 0.79% 1.30% 0.60%
iKang Healthcare Group Competitors 18.29% 1.46% 2.29%


iKang Healthcare Group peers beat iKang Healthcare Group on 9 of the 10 factors compared.

iKang Healthcare Group Company Profile

iKang Healthcare Group, Inc. provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services. The Company, through its integrated service platform, offers healthcare management solutions, including medical examinations, which cover basic examination items, such as internal, gynecology, ophthalmology, dental and X-ray, and value-added services at selected medical centers, including disease screening focusing on cancer screening, cardiovascular disease screening, certain chronic disease screening and functional medicine testing; dental care, including oral health, pediatric dentistry and cosmetic dentistry; outpatient services, such as acupuncture, obstetrics, gynecology and minor surgery, and on-site healthcare management or clinics at certain locations.

Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with's FREE daily email newsletter.

Leave a Reply